Similarly, we have previously shown that CD44 potentiates the adhesion of breast and prostate cancer cells to bone marrow endothelial cells (BMECs) in vitro [23, 24], suggesting that CD44 may contribute to the efficiency of distant metastasis through its capacity to function as an adhesion receptor, facilitating the escape of cells from the circulation. This evidence concerns the gene CD44 and prostate carcinoma.